Mounjaro is an advanced weight loss medication that supports appetite regulation and metabolic health. As a dual GIP and GLP-1 receptor agonist, it mimics the actions of two naturally occurring hormones involved in blood sugar control, digestion, and appetite signalling. By activating both GIP and GLP-1 receptors, Tirzepatide helps people feel fuller for longer, reduces food intake, and supports weight loss by improving the body’s ability to regulate energy use and metabolism.  Administered through weekly injections, Tirzepatide for weight loss is typically prescribed as part of a comprehensive treatment plan that includes a balanced diet, regular physical activity, and ongoing medical support.

Important Notice About Starting Mounjaro
If you are a new patient, or this is your first time using Mounjaro, you must begin with (2.5mg).

Mounjaro is a step-up medication designed to be introduced gradually. 

Even if you are eager to begin seeing results, the first month is essential to help your body adjust to the medication safely and effectively. Skipping this step is not an option, it is a medical requirement.

Prescription-Only Medication Notice:
This peptide is a Schedule 4 prescription-only treatment. Selecting this product does not guarantee access or approval. All patients must undergo a consultation with an AHPRA-registered medical practitioner, who will assess clinical suitability and determine whether this treatment is appropriate. Prescriptions are issued only when medically justified and in line with regulatory guidelines.

**All peptide therapies available through PHYX require a medical consultation and prescription. Treatment suitability is determined by an AHPRA-registered clinician.**